Company Filing History:
2 out of 223 
2 out of 1,476 
1 out of 238 
Years Active: 2020-2024
Title: Marco Bezzi: Innovator in Cancer Treatment
Introduction
Marco Bezzi is a notable inventor based in Singapore, recognized for his contributions to cancer research and treatment. He holds two patents that focus on innovative methods for inhibiting cancer cell growth.
Latest Patents
Bezzi's latest patents revolve around the direct and selective inhibition of MDM4 for the treatment of cancer. This application specifically addresses cancers with high MDM4 protein levels, such as melanoma, breast, colon, lung cancers, glioblastoma, and retinoblastoma. The research demonstrates that inhibiting MDM4, for instance through antisense RNA, can lead to the growth inhibition of cancer cells and enhance sensitivity to chemotherapy or targeted therapies. Additionally, the patents provide straightforward methods for identifying patients who would benefit most from this treatment by comparing specific transcript levels.
Career Highlights
Throughout his career, Marco Bezzi has worked with various organizations, including Vib Vzw and the Agency for Science, Technology and Research. His work has significantly impacted the field of cancer treatment, showcasing his dedication to advancing medical science.
Collaborations
Bezzi has collaborated with esteemed colleagues such as Jean-Christophe Marine and Ernesto Guccione, further enriching his research and contributions to the field.
Conclusion
Marco Bezzi's innovative work in cancer treatment through the inhibition of MDM4 highlights his role as a significant inventor in the medical field. His patents and collaborations reflect a commitment to improving patient outcomes in cancer therapy.